What Quality by Design Delivers for Pharma TeamsUntitledA Science-Based Route to Built-In Quality
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into a product from the design stage rather than testing it in at the end. This Quality by Design training in Mongolia gives formulation, process, analytical, quality and regulatory professionals a practical command of the QbD framework and the tools that make it work on real development projects. The programme is grounded in the ICH guidelines that define modern pharmaceutical development: ICH Q8(R2) Pharmaceutical Development, ICH Q9 Quality Risk Management, ICH Q10 Pharmaceutical Quality System and ICH Q11 for drug substances. You learn how the Quality Target Product Profile (QTPP), Critical Quality Attributes, risk assessment, Design of Experiments, the design space and the Control Strategy connect into one coherent, regulator-ready approach that the FDA, EMA and Mongolia's own medicines authority increasingly expect. For pharmaceutical teams in Mongolia working to lift local manufacturing toward WHO GMP standards, QbD is the capability that turns quality from an inspection activity into a design decision. Learn it with Invensis Learning and start applying it to your next formulation or process the following week.










